Amarin Corp Plc (AMRN)

[lowlevelowl88]

I like this, don't get me wrong, but could simply be a known side effect of NASH drugs is elevated trigs, which V would of course offset, and they want to compare that arm using both treatments. If trial data have shown additional synergistic effects, well then, you could very well be on to something.

Either way NASH market will be huge and for whichever Co has the biggest share, they can add revs with incremental cost if the same rep is pushing both drugs together.

GILD / NASH

A reminder that REDUCE-IT contained a NAFLD/NASH subgroup.

Has this data been publically released? NO.

Has this data been shared with GILD under NDA?Well, GILD are using VASCEPA in their trial, so use your imagination.

Additionally, a ton of outside research shows benefit of EPA for NAFLD/NASH.